<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rutigliano HM</submitter><funding>NICHD NIH HHS</funding><pagination>e13520</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9285385</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>87(3)</volume><pubmed_abstract>&lt;h4>Problem&lt;/h4>A significant rate of spontaneous abortion is observed in cattle pregnancies produced by somatic cell nuclear transfer (SCNT). Major histocompatibility complex class I (MHC-I) proteins are abnormally expressed on the surface of trophoblast cells from SCNT conceptuses.&lt;h4>Method of study&lt;/h4>MHC-I homozygous compatible (n = 9), homozygous incompatible (n = 8), and heterozygous incompatible (n = 5) pregnancies were established by SCNT. Eight control pregnancies were established by artificial insemination. Uterine and trophoblast samples were collected on day 35 ±1 of pregnancy, the expression of immune-related genes was examined by qPCR, and the expression of trophoblast microRNAs was assessed by sequencing.&lt;h4>Results&lt;/h4>Compared to the control group, trophoblast from MHC-I heterozygous incompatible pregnancies expressed increased levels of CD28, CTLA4, CXCL8, IFNG, IL1A, IL2, IL10, IL12B, TBX21, and TNF, while GNLY expression was downregulated. The MHC-I homozygous incompatible treatment group expressed increased levels of IFNG, IL1A, and IL2 while the MHC-I homozygous compatible group did not differentially express any genes compared to the control group. In the endometrium, relative to the control group, MHC-I heterozygous incompatible pregnancies expressed increased levels of CD28, CTLA4, CXCL8, IFNG, IL10, IL12B, and TNF, while GATA3 expression was downregulated. The MHC-I homozygous incompatible group expressed decreased amounts of CSF2 transcripts compared with the control group but did not have abnormal expression of any other immune-related genes. MHC-I incompatible pregnancies had 40 deregulated miRNAs compared to control pregnancies and 62 deregulated microRNAs compared to MHC-I compatible pregnancies.&lt;h4>Conclusions&lt;/h4>MHC-I compatibility between the dam and fetus prevented an exacerbated maternal immune response from being mounted against fetal antigens.</pubmed_abstract><journal>American journal of reproductive immunology (New York, N.Y. : 1989)</journal><pubmed_title>Increased expression of pro-inflammatory cytokines at the fetal-maternal interface in bovine pregnancies produced by cloning.</pubmed_title><pmcid>PMC9285385</pmcid><funding_grant_id>R01 HD055502</funding_grant_id><pubmed_authors>Wilhelm A</pubmed_authors><pubmed_authors>Duhan N</pubmed_authors><pubmed_authors>White KL</pubmed_authors><pubmed_authors>Umbaugh JJ</pubmed_authors><pubmed_authors>Davies CJ</pubmed_authors><pubmed_authors>Rutigliano HM</pubmed_authors><pubmed_authors>Kaundal R</pubmed_authors><pubmed_authors>Schlafer DH</pubmed_authors><pubmed_authors>Thomas AJ</pubmed_authors><pubmed_authors>Sessions BR</pubmed_authors><pubmed_authors>Hicks BA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Increased expression of pro-inflammatory cytokines at the fetal-maternal interface in bovine pregnancies produced by cloning.</name><description>&lt;h4>Problem&lt;/h4>A significant rate of spontaneous abortion is observed in cattle pregnancies produced by somatic cell nuclear transfer (SCNT). Major histocompatibility complex class I (MHC-I) proteins are abnormally expressed on the surface of trophoblast cells from SCNT conceptuses.&lt;h4>Method of study&lt;/h4>MHC-I homozygous compatible (n = 9), homozygous incompatible (n = 8), and heterozygous incompatible (n = 5) pregnancies were established by SCNT. Eight control pregnancies were established by artificial insemination. Uterine and trophoblast samples were collected on day 35 ±1 of pregnancy, the expression of immune-related genes was examined by qPCR, and the expression of trophoblast microRNAs was assessed by sequencing.&lt;h4>Results&lt;/h4>Compared to the control group, trophoblast from MHC-I heterozygous incompatible pregnancies expressed increased levels of CD28, CTLA4, CXCL8, IFNG, IL1A, IL2, IL10, IL12B, TBX21, and TNF, while GNLY expression was downregulated. The MHC-I homozygous incompatible treatment group expressed increased levels of IFNG, IL1A, and IL2 while the MHC-I homozygous compatible group did not differentially express any genes compared to the control group. In the endometrium, relative to the control group, MHC-I heterozygous incompatible pregnancies expressed increased levels of CD28, CTLA4, CXCL8, IFNG, IL10, IL12B, and TNF, while GATA3 expression was downregulated. The MHC-I homozygous incompatible group expressed decreased amounts of CSF2 transcripts compared with the control group but did not have abnormal expression of any other immune-related genes. MHC-I incompatible pregnancies had 40 deregulated miRNAs compared to control pregnancies and 62 deregulated microRNAs compared to MHC-I compatible pregnancies.&lt;h4>Conclusions&lt;/h4>MHC-I compatibility between the dam and fetus prevented an exacerbated maternal immune response from being mounted against fetal antigens.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2024-11-09T19:02:13.534Z</modification><creation>2022-08-06T14:40:12.179Z</creation></dates><accession>S-EPMC9285385</accession><cross_references><pubmed>34974639</pubmed><doi>10.1111/aji.13520</doi></cross_references></HashMap>